DE69029100T2 - Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris - Google Patents
Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgarisInfo
- Publication number
- DE69029100T2 DE69029100T2 DE69029100T DE69029100T DE69029100T2 DE 69029100 T2 DE69029100 T2 DE 69029100T2 DE 69029100 T DE69029100 T DE 69029100T DE 69029100 T DE69029100 T DE 69029100T DE 69029100 T2 DE69029100 T2 DE 69029100T2
- Authority
- DE
- Germany
- Prior art keywords
- ketoconazole
- retinoid
- acne vulgaris
- treat acne
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898910069A GB8910069D0 (en) | 1989-05-03 | 1989-05-03 | Method of topically treating acne vulgaris |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69029100D1 DE69029100D1 (de) | 1996-12-19 |
DE69029100T2 true DE69029100T2 (de) | 1997-04-03 |
Family
ID=10656092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69029100T Expired - Fee Related DE69029100T2 (de) | 1989-05-03 | 1990-04-26 | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0396184B1 (de) |
JP (1) | JP2833711B2 (de) |
KR (1) | KR0161526B1 (de) |
AT (1) | ATE145136T1 (de) |
AU (1) | AU626672B2 (de) |
CA (1) | CA2015838C (de) |
DE (1) | DE69029100T2 (de) |
DK (1) | DK0396184T3 (de) |
ES (1) | ES2096577T3 (de) |
GB (1) | GB8910069D0 (de) |
GR (1) | GR3022519T3 (de) |
IE (1) | IE74192B1 (de) |
IL (1) | IL94267A (de) |
PT (1) | PT93935B (de) |
SG (1) | SG47035A1 (de) |
ZA (1) | ZA903339B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559149A (en) | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
US5583136A (en) * | 1990-01-29 | 1996-12-10 | Johnson & Johnson Consumer Products, Inc. | Retinoid containing skin care compositions containing imidazoles |
GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
LU87843A1 (fr) * | 1990-11-15 | 1992-08-25 | Cird Galderma | Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique |
GR1002207B (en) * | 1992-08-06 | 1996-03-27 | Johnson & Johnson Consumer | Skin care compositions containing imidazoles. |
AU5955094A (en) * | 1992-12-22 | 1994-07-19 | Sepracor, Inc. | Methods and compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections |
ES2064288B1 (es) * | 1993-07-06 | 1995-08-01 | Ornosa Enrique Viayna | Composicion para el tratamiento de afecciones cutaneas, su preparacion y su uso. |
TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
US5556871A (en) * | 1995-04-24 | 1996-09-17 | President & Fellows Of Harvard College | Method for treating epithelial precancerous lesions with topical inidazoles |
GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
US5716627A (en) * | 1996-04-25 | 1998-02-10 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester |
US6150403A (en) * | 1997-10-14 | 2000-11-21 | The Procter & Gamble Company | Topical compositions for regulating the oily/shiny appearance of skin |
KR100247558B1 (ko) * | 1997-11-24 | 2000-05-01 | 김충섭 | 사이클로덱스트린을 이용한 이온토포레시스 개선방법 |
US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
DE19943678A1 (de) * | 1999-09-13 | 2001-03-15 | Beiersdorf Ag | Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen |
GB2365770B (en) * | 2000-08-18 | 2002-07-31 | Diomed Dev Ltd | Antifungal ketoconazole composition for topical use |
DE10131796A1 (de) * | 2001-06-30 | 2003-01-16 | Beiersdorf Ag | Verwendung von Cardiolipin in kosmetischen oder dermatologischen Zubereitungen |
DE10151245A1 (de) * | 2001-10-17 | 2003-05-15 | Beiersdorf Ag | Kosmetische und/oder dermatologische Wirkstoffkombination |
KR100432449B1 (ko) * | 2001-11-30 | 2004-05-22 | 우원홍 | 케토코나졸 함유 피부 미백용 외용제 조성물 |
FR2835434B1 (fr) * | 2002-02-01 | 2006-03-03 | Lvmh Rech | Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee |
US20090117203A1 (en) * | 2006-03-23 | 2009-05-07 | Tmrc Co., Ltd. | Kit for cancer treatment and pharmaceutical composition for cancer treatment |
WO2013107809A1 (en) * | 2012-01-19 | 2013-07-25 | Merz Pharma Gmbh & Co. Kgaa | Use of azole antifungals for the treatment of actinic keratosis |
CN108066342A (zh) * | 2016-11-17 | 2018-05-25 | 江苏灵豹药业股份有限公司 | 一种复方酮康唑乳膏剂及其制备方法 |
CN115671285B (zh) * | 2022-08-24 | 2024-01-05 | 上海市皮肤病医院 | 一种抗真菌溶液及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
GB2068228B (en) * | 1980-01-24 | 1984-02-29 | Janssen Pharmaceutica Nv | Anti-microbial compositions for the topical treatment of acne vulgaris |
US4371673A (en) * | 1980-07-21 | 1983-02-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble forms of retinoids |
GB2097783B (en) * | 1981-04-23 | 1984-12-12 | Dermal Lab Ltd | Imidazoles |
US4569935A (en) * | 1983-03-17 | 1986-02-11 | University Of Tennessee Research Corp. | Topical treatment of psoriasis with imidazole antibiotics |
DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
EP0270316A3 (de) * | 1986-12-04 | 1989-12-06 | Pfizer Inc. | Topische Zusammensetzungen mit Gehalt an 1-substituierten Imidazolen und nicht-steroiden entzündungshemmenden Mitteln zur Behandlung von Akne |
US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
-
1989
- 1989-05-03 GB GB898910069A patent/GB8910069D0/en active Pending
-
1990
- 1990-04-26 DK DK90201054.5T patent/DK0396184T3/da active
- 1990-04-26 ES ES90201054T patent/ES2096577T3/es not_active Expired - Lifetime
- 1990-04-26 AT AT90201054T patent/ATE145136T1/de not_active IP Right Cessation
- 1990-04-26 EP EP90201054A patent/EP0396184B1/de not_active Expired - Lifetime
- 1990-04-26 DE DE69029100T patent/DE69029100T2/de not_active Expired - Fee Related
- 1990-04-26 SG SG1996003667A patent/SG47035A1/en unknown
- 1990-05-01 CA CA002015838A patent/CA2015838C/en not_active Expired - Fee Related
- 1990-05-02 JP JP2115340A patent/JP2833711B2/ja not_active Expired - Fee Related
- 1990-05-02 IL IL9426790A patent/IL94267A/en not_active IP Right Cessation
- 1990-05-02 PT PT93935A patent/PT93935B/pt not_active IP Right Cessation
- 1990-05-02 IE IE160790A patent/IE74192B1/en not_active IP Right Cessation
- 1990-05-02 AU AU54711/90A patent/AU626672B2/en not_active Ceased
- 1990-05-02 ZA ZA903339A patent/ZA903339B/xx unknown
- 1990-05-03 KR KR1019900006234A patent/KR0161526B1/ko not_active IP Right Cessation
-
1997
- 1997-02-12 GR GR960403427T patent/GR3022519T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU5471190A (en) | 1990-11-15 |
JP2833711B2 (ja) | 1998-12-09 |
KR900017590A (ko) | 1990-12-19 |
ZA903339B (en) | 1992-01-29 |
EP0396184B1 (de) | 1996-11-13 |
PT93935B (pt) | 1996-11-29 |
KR0161526B1 (ko) | 1998-12-01 |
GR3022519T3 (en) | 1997-05-31 |
CA2015838A1 (en) | 1990-11-03 |
AU626672B2 (en) | 1992-08-06 |
IE901607L (en) | 1990-11-03 |
EP0396184A2 (de) | 1990-11-07 |
DK0396184T3 (da) | 1996-12-30 |
IL94267A (en) | 1994-11-11 |
CA2015838C (en) | 2002-08-27 |
IE74192B1 (en) | 1997-07-16 |
EP0396184A3 (de) | 1992-05-20 |
JPH02295927A (ja) | 1990-12-06 |
ES2096577T3 (es) | 1997-03-16 |
GB8910069D0 (en) | 1989-06-21 |
SG47035A1 (en) | 1998-03-20 |
PT93935A (pt) | 1991-02-08 |
DE69029100D1 (de) | 1996-12-19 |
IL94267A0 (en) | 1991-03-10 |
ATE145136T1 (de) | 1996-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69029100D1 (de) | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris | |
ATE214933T1 (de) | Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten | |
DE3752045T2 (de) | Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten | |
EP0336880A3 (de) | Verwendung von topisch applizierbaren Präparaten zur Behandlung der Altershaut | |
DE69527765T2 (de) | Verwendung von Hyaluronsäure oder sein Salz zur Behandlung von Hauterkrankungen | |
DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
GR3026086T3 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
DE69818823D1 (de) | Dipohosphonsäuresalze für die behandlung von osteoporose | |
ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
ATE179594T1 (de) | Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie | |
DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
ATE206052T1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
DE68905657T2 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
ATE234613T1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
DE3784738T2 (de) | Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten. | |
ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
DE69715227D1 (de) | Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit | |
DE69529070T2 (de) | Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv | |
DE3887005T2 (de) | Mittel zur Behandlung von Nierenbeschwerden. | |
ATE56360T1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |